Inventor · disambiguated record
Thijn R. Brummelkamp
Also filed as: BRUMMELKAMP THIJN · BRUMMELKAMP THIJN R · BRUMMELKAMP THIJN REINOUT
6 granted patents·6 pending applications·32 citations·filing 2002–2022
74Inventor score
Files withSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS5BRUMMELKAMP THIJN R2CANCER REC TECH LTD1CHANDRAN KARTIK1HARVARD COLLEGE1
Top patents by PatentIndex Score
12 records- 0181US7241618B2Expression systemCANCER REC TECH LTD·Filed 2002·Granted Jul 10, 2007·31 cites·16 claims
- 0269US9234885B2Methods and assays for treating filoviridae infectionsCHANDRAN KARTIK·Filed 2012·Granted Jan 12, 2016·1 cites·9 claims
- 0363US11667928B2Compositions and methods for mammalian genetics and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2018·Granted Jun 6, 2023·0 cites·5 claims
- 0459US2025011734A1Dgat1/2-independent enzyme synthesizing storage lipids (diesl)STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2022·Application pending·0 cites
- 0553US2022087981A1Treating pathological conditions by direct and indirect targeting of sirpa-cd47 interactionSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2021·Application pending·0 cites
- 0651US2019309287A1Assays to identify genetic elements affecting phenotypeSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2019·Application pending·0 cites
- 0747US8748097B1Identification of agents for treating calcium disorders and uses thereofHARVARD COLLEGE·Filed 2012·Granted Jun 10, 2014·0 cites·11 claims
- 0846US10351845B2Assays to identify genetic elements affecting phenotypeSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2016·Granted Jul 16, 2019·0 cites·20 claims
- 0943US2019365717A1Treating pathological conditions by direct and indirect targeting of sirpa-cd47 interactionSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2019·Application pending·0 cites
- 1038US2012190011A1Compositions and methods for mammalian genetics and uses thereofBRUMMELKAMP THIJN R·Filed 2010·Application pending·0 cites
- 1138US2003144232A1Expression systemFiled 2002·Application pending·0 cites
- 1232US9011821B2PLA2G16 as a target for antiviral compoundsBRUMMELKAMP THIJN R·Filed 2011·Granted Apr 21, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Thijn R. Brummelkamp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →